|
GYRE Gyre Therapeutics Inc 1124105 |
| Balance Sheet |
|
Current Assets
|
$91,732,000.00 |
|
Assets
|
$162,015,000.00 |
|
Current Liabilities
|
$19,788,000.00 |
|
Liabilities
|
$25,030,000.00 |
|
Equity
|
$101,309,000.00 |
|
Shares Out
|
91337121.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$3,180,000.00 |
|
Investing Cash Flow
|
$-3,055,000.00 |
| Market Analysis |
Market Cap
|
$530,668,673.01 |
|
Price
|
$5.90 |
|
BVPS
|
1.11 |
|
PB
|
5.23 |
|
EPS
|
-0.10 |
|
PS
|
7.44 |
|
FCF
|
$3,002,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.02 |
|
|
2026-05-07 |
-0.10 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
0.00 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GYRE documents filed with the SEC.
GYRE Filings
Clear
